Repare Therapeutics

RPTX · NASDAQ🇨🇦

Overview

Earnings Dividends Seasonality Metrics

NOV

14

Q3 2025

Reported

Reported earnings 3 months ago

Previous year: -$0.81

Restructuring expenses

$1.83M

Cash and Equivalents

$72.8M

Previous year: $80.5M

-9.6%

Loading...

Repare Therapeutics

Unlock previous datapoints

Upgrade

Repare Therapeutics

Unlock previous datapoints

Upgrade

Repare Therapeutics Revenue by Geographic Location

Revenue by Geographic Location

Switzerland Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$114M

P/E Ratio

-1.54

Sector

N/A

Industry

N/A

52-Week High

$2.61

52-Week Low

$0.897

Net R&D expenses

$7.5M

G&A expenses

$4.55M

Restructuring expenses

$1.83M

Interest income

$2.22M

Income tax expense

$145K

Products

Get in Touch

Resources

Repare Therapeutics

Repare Therapeutics

Repare Therapeutics

Repare Therapeutics Revenue by Geographic Location

Revenue by Geographic Location

Switzerland Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics